BiPar Sciences Finds $35M
Brisbane-based BiPar Sciences announced Monday that it has raised $35M in a Series B funding. The round was led by Domain Associates. Existing investors Vulcan Capital, Canaan Partners, PolyTechnos Venture-Partners, Asset Management Company and Quantum Technology Partners also participated in the round. BiPar is developing compounds that are targeted at inhibiting tumors and for new cancer therapies.
posted on Monday, February 26, 2007 (Link to more information)
Related companies:
BiPar Sciences
Related stories:
> BiPar Sciences Acquired By Sanofi-aventis
> BiPar Sciences Raises $20M In Debt, Equity
> NextBio Finds $7M For Life Sciences Search
> Benchling Finds $7M For Life Sciences Software
> Aesthetics Sciences Raises $6M
silicontap.com Home